These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 19818505)

  • 1. Mortality associated with resistant cytomegalovirus among patients with cytomegalovirus retinitis and AIDS.
    Jabs DA; Martin BK; Forman MS;
    Ophthalmology; 2010 Jan; 117(1):128-132.e2. PubMed ID: 19818505
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of ganciclovir versus foscarnet in ganciclovir-resistant cytomegalovirus retinitis: A case report.
    Lee HJ; Woo SJ
    Eur J Ophthalmol; 2023 Sep; 33(5):NP105-NP108. PubMed ID: 36314436
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of host genetic risk factors with the course of cytomegalovirus retinitis in patients infected with human immunodeficiency virus.
    Sezgin E; van Natta ML; Ahuja A; Lyon A; Srivastava S; Troyer JL; O'Brien SJ; Jabs DA;
    Am J Ophthalmol; 2011 Jun; 151(6):999-1006.e4. PubMed ID: 21396623
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Non-cytomegalovirus ocular opportunistic infections in patients with acquired immunodeficiency syndrome.
    Gangaputra S; Drye L; Vaidya V; Thorne JE; Jabs DA; Lyon AT;
    Am J Ophthalmol; 2013 Feb; 155(2):206-212.e5. PubMed ID: 23068916
    [TBL] [Abstract][Full Text] [Related]  

  • 5. EFFICACY OF MARIBAVIR IN VALGANCICLOVIR-RESISTANT CYTOMEGALOVIRUS RETINITIS.
    Tsui JC; Huang V; Kolomeyer AM; Miller CG; Mishkin A; Maguire AM
    Retin Cases Brief Rep; 2024 Mar; 18(2):164-167. PubMed ID: 36730596
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Race and the treatment of cytomegalovirus retinitis in a cohort of patients with acquired immunodeficiency syndrome.
    Wutoh AK; Hidalgo J; Bareta J; Rhee W; Beardsley R; Steidl S
    J Natl Med Assoc; 1998 Apr; 90(4):214-20. PubMed ID: 9581441
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Classification Criteria for Cytomegalovirus Retinitis.
    Standardization of Uveitis Nomenclature (SUN) Working Group
    Am J Ophthalmol; 2021 Aug; 228():245-254. PubMed ID: 33845015
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Incidence Rate and Risk Factors for Contralateral Eye Involvement among Patients with AIDS and Cytomegalovirus Retinitis Treated with Local Therapy.
    Sittivarakul W; Benjhawaleemas T; Aui-Aree N; Jirarattanasopa P; Liabsuetrakul T
    Ocul Immunol Inflamm; 2015 Aug; ():1-7. PubMed ID: 26258284
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytomegalovirus (CMV) Polyradiculopathy: An Important "AIDS-Defining" Illness Complication.
    Finessi A; Aziz MA; Izquierdo-Pretel G; Bracho A
    Cureus; 2024 Apr; 16(4):e58230. PubMed ID: 38752099
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytomegalovirus retinitis in the highly active anti-retroviral therapy era.
    Ude IN; Yeh S; Shantha JG
    Ann Eye Sci; 2022 Mar; 7():. PubMed ID: 35498636
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Synthesis and Anti-Cytomegalovirus Activity of Piperidine-4-Carboxamides.
    Guo X; Ghosh AK; Keyes RF; Peterson F; Forman M; Meyers DJ; Arav-Boger R
    Viruses; 2022 Jan; 14(2):. PubMed ID: 35215828
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Continuous High-Dose (6 mg) vs. Low-Dose (3 mg) Intravitreal Ganciclovir for Cytomegalovirus Retinitis After Haploidentical Hematopoietic Stem Cell Transplantation: A Randomized Controlled Study.
    Chen WB; Long Z; Hou J; Miao H; Zhao MW
    Front Med (Lausanne); 2021; 8():750760. PubMed ID: 35004721
    [No Abstract]   [Full Text] [Related]  

  • 13. Management of cytomegalovirus corneal endotheliitis.
    Wong AHY; Kua WN; Young AL; Wan KH
    Eye Vis (Lond); 2021 Jan; 8(1):3. PubMed ID: 33441165
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Digitoxin Suppresses Human Cytomegalovirus Replication via Na
    Mukhopadhyay R; Venkatadri R; Katsnelson J; Arav-Boger R
    J Virol; 2018 Mar; 92(6):. PubMed ID: 29321306
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and Mechanism of Action of Low Dose Emetine against Human Cytomegalovirus.
    Mukhopadhyay R; Roy S; Venkatadri R; Su YP; Ye W; Barnaeva E; Mathews Griner L; Southall N; Hu X; Wang AQ; Xu X; Dulcey AE; Marugan JJ; Ferrer M; Arav-Boger R
    PLoS Pathog; 2016 Jun; 12(6):e1005717. PubMed ID: 27336364
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Late emergence of A594V and L595W mutations related to ganciclovir resistance in a patient with HCMV retinitis and long-term HIV progression.
    Slavov SN; Vilar FC; Wagatsuma VM; Santana RC; Machado AA; Fonseca BA; Kashima S; Covas DT
    Braz J Med Biol Res; 2015 Sep; 48(9):777-81. PubMed ID: 26270327
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro combination of anti-cytomegalovirus compounds acting through different targets: role of the slope parameter and insights into mechanisms of Action.
    Cai H; Kapoor A; He R; Venkatadri R; Forman M; Posner GH; Arav-Boger R
    Antimicrob Agents Chemother; 2014; 58(2):986-94. PubMed ID: 24277030
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Wnt modulating agents inhibit human cytomegalovirus replication.
    Kapoor A; He R; Venkatadri R; Forman M; Arav-Boger R
    Antimicrob Agents Chemother; 2013 Jun; 57(6):2761-7. PubMed ID: 23571549
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of treatment regimens for cytomegalovirus retinitis in patients with AIDS in the era of highly active antiretroviral therapy.
    Jabs DA; Ahuja A; Van Natta M; Dunn JP; Yeh S;
    Ophthalmology; 2013 Jun; 120(6):1262-70. PubMed ID: 23419804
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human cytomegalovirus inhibition by cardiac glycosides: evidence for involvement of the HERG gene.
    Kapoor A; Cai H; Forman M; He R; Shamay M; Arav-Boger R
    Antimicrob Agents Chemother; 2012 Sep; 56(9):4891-9. PubMed ID: 22777050
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.